STRATA Skin Sciences (SSKN) Cash & Current Investments (2010 - 2025)

STRATA Skin Sciences' Cash & Current Investments history runs 16 years deep, the most recent figure standing at $7.9 million for Q4 2025.

• In Q4 2025, Cash & Current Investments fell 7.95% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at $7.9 million (down 7.95% YoY), while the FY2025 annual figure was $7.9 million, down 7.95% from the prior year.
• Cash & Current Investments came in at $7.9 million for Q4 2025 at STRATA Skin Sciences, up from $7.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $17.5 million in Q1 2021 to a low of $4.2 million in Q1 2023.
• A 5-year average of $9.4 million and a median of $8.4 million in 2023 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments plunged 61.68% in 2023 and surged 56.98% in 2024, its largest moves.
• STRATA Skin Sciences' Cash & Current Investments stood at $12.6 million in 2021, then slumped by 46.01% to $6.8 million in 2022, then grew by 19.47% to $8.1 million in 2023, then climbed by 5.88% to $8.6 million in 2024, then declined by 7.95% to $7.9 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $7.9 million, $7.1 million, and $6.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison